Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

The search for a cure news

Show

From To
Dr. Carl June weaves together HIV and cancer research to advance cures for both

CAR T-cell pioneer and one-time bone marrow transplant fellow will give keynote at HIV cure conference.

Published
17 August 2017
From
Fred Hutch News Service
Understanding Exactly How the ‘Berlin Patient’ Was Cured

The strongest proof that HIV can be cured comes from the case of Timothy Brown, the “Berlin patient.” That triumph was predicated on physicians taking advantage of nature’s own experiment: the existence of a genetic mutation in a normal cell protein, CCR5, the main co-receptor that HIV uses to gain entry into a cell.

Published
16 August 2017
From
amfAR
Why curing HIV may be like curing cancer – and may be as difficult

For the last few years, a specialist symposium on HIV cure research has preceded the International AIDS Society (IAS) Conferences and this one was no exception,

Published
03 August 2017
By
Gus Cairns
What marks out HIV controllers from others?

What if we are asking the wrong, question, though? What if trying to destroy or at least expose and inactivate every cell containing HIV is not the

Published
03 August 2017
By
Gus Cairns
Can we achieve a complete HIV cure in more patients?

What all the different approaches discussed in the previous report have in common is to put HIV infection into persistent remission, but they do not completely remove

Published
03 August 2017
By
Gus Cairns
VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

A broadly neutralising antibody modestly delayed the resurgence of viral replication following interruption of antiretroviral therapy (ART) started during very early infection, but all study participants ultimately experienced

Published
02 August 2017
By
Liz Highleyman
Vorinostat renders dormant HIV infection vulnerable to clearance

For the first time researchers at the University of North Carolina at Chapel Hill have developed an assay that can measure antigen production and clearance caused by a latency-reversing agent.

Published
01 August 2017
From
Eurekalert Medicine & Health
What can science learn from a child who has controlled HIV without drugs for more than 8 years?

An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people to control the virus for prolonged periods without treatment.

Published
27 July 2017
From
Science
Antibody helps keep man's HIV at bay for 10 months

An experimental therapy has held back one man's HIV infection for 10 months, doctors have reported. He was one of 18 people in a small trial testing injections of "broadly neutralising antibodies" - the natural weapons of the immune system.

Published
26 July 2017
From
BBC News
South African child has controlled HIV off treatment for 8.5 years

A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received HIV treatment for 40 weeks during infancy has suppressed the virus

Published
24 July 2017
By
Keith Alcorn
← First12345...43Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.